EcoR1 Capital, LLC Quant / Systematic

CIK: 0001587114 · Show all filings

Period: Q3 2015 (← Previous) (Next →)

Filing Date: Nov 16, 2015

Total Value ($000): $219,698 (89.9% shares, 10.1% debt)

Holdings (25)

FIBROGEN INC 12.3%
Value ($000) $26,970 Shares 1,230,391 Est. Cost $24.72 Unrealized
ATARA BIOTHERAPEUTICS INC 11.5%
Value ($000) $25,261 Shares 803,458 Est. Cost $36.04 Unrealized
ARRAY BIOPHARMA INC 10.1%
Value ($000) $22,210 Shares 22,534,000 Est. Cost $0.96 Unrealized
RETROPHIN INC 9.3%
Value ($000) $20,415 Shares 1,007,660 Est. Cost $21.51 Unrealized
EPIZYME INC 8.7%
Value ($000) $19,196 Shares 1,492,700 Est. Cost $19.11 Unrealized
ASSEMBLY BIOSCIENCES INC 8.2%
Value ($000) $18,040 Shares 1,887,069 Est. Cost $9.75 Unrealized
KITE PHARMA INC 7.1%
Value ($000) $15,668 Shares 281,400 Est. Cost $57.67 Unrealized
FLEX PHARMA INC 5.1%
Value ($000) $11,214 Shares 933,691 Est. Cost $19.13 Unrealized
COLL COLLEGIUM PHARMACEUTICAL INC 4.7%
Value ($000) $10,284 Shares 465,118 Est. Cost $17.29 Unrealized +4.1%
ATYR PHARMA INC 3.9%
Value ($000) $8,623 Shares 840,462 Est. Cost $18.52 Unrealized
NABRIVA THERAPEUTICS AG 3.6%
Value ($000) $7,938 Shares 835,530 Est. Cost $9.50 Unrealized
KINDRED BIOSCIENCES INC 3.1%
Value ($000) $6,882 Shares 1,323,431 Est. Cost $7.40 Unrealized
GENVEC INC 2.1%
Value ($000) $4,589 Shares 1,986,413 Est. Cost $2.08 Unrealized
CELLADON CORP 1.4%
Value ($000) $2,985 Shares 2,843,170 Est. Cost $1.26 Unrealized
ONCOTHYREON INC 1.2%
Value ($000) $2,585 Shares 943,500 Est. Cost $2.74 Unrealized
AKARI THERAPEUTICS PLC 1.1%
Value ($000) $2,417 Shares 100,709 Est. Cost $24.00 Unrealized
FORWARD PHARMA A/S 1.1%
Value ($000) $2,403 Shares 101,995 Est. Cost $23.61 Unrealized
FIVE PRIME THERAPEUTICS INC 1.0%
Value ($000) $2,293 Shares 149,000 Est. Cost $15.39 Unrealized
CALITHERA BIOSCIENCES INC 1.0%
Value ($000) $2,256 Shares 415,480 Est. Cost $15.57 Unrealized
GILEAD SCIENCES INC 1.0%
Value ($000) $2,148 Shares 3,255 Est. Cost Unrealized
OREXIGEN THERAPEUTICS INC 0.9%
Value ($000) $1,979 Shares 937,958 Est. Cost $2.11 Unrealized
QLT INC 0.8%
Value ($000) $1,699 Shares 638,900 Est. Cost $3.58 Unrealized
VALEANT PHARMACEUTICALS INTL 0.6%
Value ($000) $1,347 Shares 1,265 Est. Cost Unrealized
CATALYST BIOSCIENCES INC 0.1%
Value ($000) $261 Shares 56,000 Est. Cost $4.66 Unrealized
REGULUS THERAPEUTICS INC 0.0%
Value ($000) $35 Shares 1,280 Est. Cost Unrealized